THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND;AUTOIMMUNE TECHNOLOGIES, LLC
发明人:
GARRY, ROBERT F.,WILSON, RUSSELL B.
申请号：
CA2906519
公开号：
CA2906519A1
申请日:
2014.03.13
申请国别(地区):
CA
年份:
2014
代理人:
摘要：
Immunogenic influenza hemagglutinin-derived peptide conjugates described herein induce a specific therapeutic antibody response against influenza virus. The immunogenic peptide conjugates comprise a segment from the fusion initiation region (FIR) domain of an influenza hemagglutinin protein conjugated to a carrier protein, such as keyhole limpet hemocyanin (KLH), bovine serum albumin (BSA), an influenza hemagglutinin (HA) protein (i.e., full length HA), and the like. The immunogenic peptide conjugates described herein can be utilized to treat or prevent influenza infection and to prepare influenza-specific therapeutic antibodies that interfere with influenza virus-host cell membrane fusion. The peptide conjugates can be formulated in pharmaceutical compositions useful for broad spectrum treatment or prevention of influenza infections.
